The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of everolimus (E) and sorafenib (S) in patients (PTS) with metastatic differentiated thyroid cancer who have progressed on sorafenib alone.
 
Marcia S. Brose
Honoraria - Bayer; Exelixis; Onyx
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Exelixis; Onyx; Oxigene
Research Funding - Bayer (Inst); Eisai (Inst); Exelixis (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Onyx
 
Andrea B. Troxel
Consulting or Advisory Role - Asubio Pharma
Research Funding - The Vitality Group (Inst)
Travel, Accommodations, Expenses - The Vitality Group
 
Mark Yarchoan
No Relationships to Disclose
 
Aaron Benjamin Cohen
No Relationships to Disclose
 
Kathleen Harlacker
No Relationships to Disclose
 
Nikolas A Dyanick
No Relationships to Disclose
 
Zakkiyya A Posey
No Relationships to Disclose
 
Ramkrishna Makani
No Relationships to Disclose
 
Parna Prajapati
No Relationships to Disclose
 
Larisa M. Zifchak
No Relationships to Disclose
 
Carolyn Grande
No Relationships to Disclose
 
Christian Michael Squillante
No Relationships to Disclose